UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): |
(Exact name of Registrant as Specified in Its Charter)
(State or Other Jurisdiction |
(Commission File Number) |
(IRS Employer |
||
|
|
|
|
|
|
||||
|
||||
(Address of Principal Executive Offices) |
|
(Zip Code) |
Registrant’s Telephone Number, Including Area Code: |
(Former Name or Former Address, if Changed Since Last Report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
Securities registered pursuant to Section 12(b) of the Act:
|
|
Trading |
|
|
|
|
|||
|
|
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).
Emerging growth company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
Departure of Director
As previously disclosed in a Current Report on Form 8-K filed by Nuburu, Inc. (the “Company”) with the Securities and Exchange Commission (the “SEC”) on May 10, 2023, Dr. Ake Almgren notified the Company on May 9, 2023 of his resignation as a member of the Board of Directors (the “Board”) effective as of May 19, 2023 (the “Resignation Date”). Dr. Almgren has been serving as a member of the Board’s audit committee and nominating and corporate governance committee. Dr. Almgren resigned for personal reasons and not as the result of any disagreement with the Company on any matter relating to the Company’s operations, policies or practices.
Director Reclassification
On May 15, 2023, in order to achieve an equal apportionment of membership among the three director classes of the Board, Ron Nicol tendered his resignation as a Class II director, effective upon the Board reappointing Mr. Nicol as a Class I director. On May 15, 2023, the Board reappointed Mr. Nicol as a Class I director effective as of the Resignation Date. Class I directors serve until the 2023 Annual Meeting of Stockholders and Class II directors serve until the 2024 Annual Meeting of Stockholders. The resignation and reappointment of Mr. Nicol was effected solely for the purpose of achieving an equal apportionment of membership among the Board’s three classes of directors, and for all other purposes, Mr. Nicol’s service on the Board is deemed to have continued uninterrupted.
Mr. Nicol will continue to serve as the chair of the Board and will continue to serve on the Board’s audit committee and compensation committee. There are no changes or impacts to any of Mr. Nicol’s compensation arrangements or equity awards as a result of his resignation as a Class II director and reappointment as a Class I director.
There are no arrangements or understandings between Mr. Nicol and any other person pursuant to which Mr. Nicol was selected as a director.
Mr. Nicol will continue to receive director compensation as described in the “Direction Compensation” section of the Company’s definitive proxy statement filed with the SEC on April 21, 2023 (the “2023 Proxy Statement”), which disclosure is incorporated herein by reference. Mr. Nicol previously entered into an indemnification agreement with the Company, the form of which was filed as Exhibit 10.29 to the Company’s Annual Report on Form 10-K, filed by the Company with the SEC on March 31, 2023, and which remains in effect as of the date hereof.
Certain transactions between the Company and Mr. Nicol required to be disclosed pursuant to Item 404(a) of Regulation S-K are described in the “Certain Relationships and Related Party Transactions” section of the 2023 Proxy Statement, which disclosure is incorporated herein by reference.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
|
|
Nuburu, Inc. |
|
|
|
|
Date: |
May 17, 2023 |
By: |
/s/ Brian Knaley |
|
|
Name: Title: |
Brian Knaley |